235 related articles for article (PubMed ID: 34248355)
1.
Pandey K; Lokhande KB; Swamy KV; Nagar S; Dake M
Bioinform Biol Insights; 2021; 15():11779322211027403. PubMed ID: 34248355
[TBL] [Abstract][Full Text] [Related]
2. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
Wakchaure PD; Ghosh S; Ganguly B
J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
[TBL] [Abstract][Full Text] [Related]
3. Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches.
Pundir H; Joshi T; Pant M; Bhat S; Pandey J; Chandra S; Tamta S
J Biomol Struct Dyn; 2022; 40(24):13366-13377. PubMed ID: 34637693
[TBL] [Abstract][Full Text] [Related]
4. Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach.
Singh R; Bhardwaj VK; Purohit R
Comput Biol Med; 2021 Dec; 139():104965. PubMed ID: 34717229
[TBL] [Abstract][Full Text] [Related]
5.
Singh P; Tripathi MK; Yasir M; Khare R; Shrivastava R
Mol Biol Res Commun; 2021 Sep; 10(3):131-140. PubMed ID: 34476266
[TBL] [Abstract][Full Text] [Related]
6. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2
Singh S; Sk MF; Sonawane A; Kar P; Sadhukhan S
J Biomol Struct Dyn; 2021 Oct; 39(16):6249-6264. PubMed ID: 32720577
[TBL] [Abstract][Full Text] [Related]
7. Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an
Ogunyemi OM; Gyebi GA; Elfiky AA; Afolabi SO; Ogunro OB; Adegunloye AP; Ibrahim IM
Antivir Chem Chemother; 2020; 28():2040206620984076. PubMed ID: 33372806
[TBL] [Abstract][Full Text] [Related]
8. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
Zhang L; Zhou R
J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
[TBL] [Abstract][Full Text] [Related]
9. Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19.
Rabie AM
Curr Res Pharmacol Drug Discov; 2021; 2():100055. PubMed ID: 34870153
[TBL] [Abstract][Full Text] [Related]
10. Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.
Sonousi A; Mahran HA; Ibrahim IM; Ibrahim MN; Elfiky AA; Elshemey WM
Pharmacol Rep; 2021 Dec; 73(6):1754-1764. PubMed ID: 34165771
[TBL] [Abstract][Full Text] [Related]
11. In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches.
Zhang C; Liu J; Sui Y; Liu S; Yang M
Sci Rep; 2023 Dec; 13(1):21404. PubMed ID: 38049492
[TBL] [Abstract][Full Text] [Related]
12. A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp).
Ribaudo G; Ongaro A; Oselladore E; Zagotto G; Memo M; Gianoncelli A
J Biomol Struct Dyn; 2022 Feb; 40(3):1101-1108. PubMed ID: 32948103
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an
Elfiky AA
J Biomol Struct Dyn; 2021 Jun; 39(9):3204-3212. PubMed ID: 32338164
[TBL] [Abstract][Full Text] [Related]
14. The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp.
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
Saudi J Biol Sci; 2021 Feb; 28(2):1426-1432. PubMed ID: 33281478
[TBL] [Abstract][Full Text] [Related]
15. State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2.
Tanimoto S; Itoh SG; Okumura H
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142270
[TBL] [Abstract][Full Text] [Related]
16. Computational insights of phytochemical-driven disruption of RNA-dependent RNA polymerase-mediated replication of coronavirus: a strategic treatment plan against coronavirus disease 2019.
Balkrishna A; Mittal R; Sharma G; Arya V
New Microbes New Infect; 2021 May; 41():100878. PubMed ID: 33815808
[TBL] [Abstract][Full Text] [Related]
17. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking.
Elghoneimy LK; Ismail MI; Boeckler FM; Azzazy HME; Ibrahim TM
Comput Biol Med; 2021 Jul; 134():104468. PubMed ID: 34015671
[TBL] [Abstract][Full Text] [Related]
18. Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus.
Tiwari V
Int J Biol Macromol; 2021 Feb; 171():358-365. PubMed ID: 33421473
[TBL] [Abstract][Full Text] [Related]
19. In silico docking analysis revealed the potential of phytochemicals present in
Hiremath S; Kumar HDV; Nandan M; Mantesh M; Shankarappa KS; Venkataravanappa V; Basha CRJ; Reddy CNL
3 Biotech; 2021 Feb; 11(2):44. PubMed ID: 33457171
[TBL] [Abstract][Full Text] [Related]
20. Binding properties of selective inhibitors of P323L mutated RdRp of SARS-CoV-2: a combined molecular screening, docking and dynamics simulation study.
Chinnamadhu A; Ramakrishnan J; Suresh S; Poomani K
J Biomol Struct Dyn; 2024 May; 42(8):4283-4296. PubMed ID: 37301607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
